Tempus, a Chicago-based biotech firm launched by businessman Eric Lefkofsky, has made large strides during the COVID-19 pandemic. Initially, the company focused on assisting physicians in tackling cancer by empowering them to analyze patient genomic data. Recently, though, Lefkofsky and Tempus have been touting the […]